SCHEMBL9818756

SCHEMBL9818756

CCCC1CC(CC(=O)O)c2ccccc2O1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.42
ALDH1A1 P00352 1/20 0.39
HPGD P15428 1/20 0.39
AKR1B1 P15121 1/20 0.38
PPARG P37231 4/20 0.38
PPARD Q03181 4/20 0.38
MTNR1A P48039 4/20 0.37
MTNR1B P49286 4/20 0.37
DGAT1 O75907 1/20 0.36
MEN1 O00255 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
HTR2B P41595 1/20 0.36
FFAR1 O14842 1/20 0.35
PPARA Q07869 1/20 0.35
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9818762 1.00 HTT (0.42) HTTALDH1A1HPGDAKR1B1PPARG
SCHEMBL9819041 0.89 HTT (0.40) HTTALDH1A1HPGDAKR1B1PPARG
SCHEMBL9819039 0.89 HTT (0.40) HTTALDH1A1HPGDAKR1B1PPARG
SCHEMBL9818872 0.85 ABCB1 (0.46) HTTHPGDAKR1B1MTNR1AMTNR1B
SCHEMBL9818878 0.85 ABCB1 (0.46) HTTHPGDAKR1B1MTNR1AMTNR1B
SCHEMBL9819040 0.82 LTB4R (0.43) HTTALDH1A1HPGDPPARGPPARD
SCHEMBL9819044 0.82 LTB4R (0.43) HTTALDH1A1HPGDPPARGPPARD
SCHEMBL9818765 0.80 AKR1B1 (0.45) HTTALDH1A1AKR1B1PPARGPPARD
SCHEMBL9818767 0.80 AKR1B1 (0.45) HTTALDH1A1AKR1B1PPARGPPARD
SCHEMBL10650423 0.80 HTR2C (0.40) HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230379-B1 CHROMAN- AND THIOCHROMAN-4-ACETIC ACIDS USEFUL IN THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1991-04-03 EP disclosed